Standardized droplet preamplification method for downstream circulating cell-free DNA analysis
Circulating cell-free DNA (ccfDNA) can be found in blood and other biofluids and is a minimally invasive biomarker for several pathological processes. As tumors become more invasive, an increasing amount of circulating tumor DNA (ctDNA) is also shed into the peripheral circulation. Combined analysis...
Saved in:
| Main Authors: | Colin Skeen, Erica D. Pratt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-03-01
|
| Series: | BioTechniques |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07366205.2025.2504287 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR
by: Stavroula Smilkou, et al.
Published: (2025-07-01) -
Species-level enumeration of low-concentration lactic acid bacteria in breast milk
by: Yue Sun, et al.
Published: (2025-12-01) -
Prognostic value of circulating HPV cell-free DNA in cervical cancer using liquid biopsy
by: Ashna Gupta, et al.
Published: (2025-04-01) -
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics
by: Lorenzo Foffano, et al.
Published: (2025-09-01) -
Integrated Analysis of Cell-Free DNA and Novel Protein Biomarkers for Stratification and Therapy Monitoring in Stage IV Pancreatic Cancer: A Preliminary Study
by: Saskia Hussung, et al.
Published: (2024-12-01)